Vice President & Chief Medical Officer (CMO) Radiometer

Vice President & Chief Medical Officer (CMO) Radiometer Bring more to life. Are you ready to shape the future of acute care diagnostics and elevate the role of medical leadership in transforming patient outcomes globally? At Radiometer, one of the world’s leading diagnostics companies and part of Danaher Diagnostics, our innovations help clinicians make critical decisions that save lives. From blood gas analysis and acute care diagnostics to connected solutions that improve clinical workflows, Radiometer is committed to advancing patient care through scientific excellence, innovation, and operational rigor. Powered by the Danaher Business System (DBS), we continuously improve how we innovate, collaborate, and deliver impact globally. The Vice President & Chief Medical Officer (CMO) is a highly strategic enterprise leader who serves as the senior medical voice for Radiometer globally. As a key member of the Radiometer Senior Leadership Team and the Danaher Diagnostics Medical Leadership Team, the CMO shapes the company’s medical, clinical, and scientific strategy across the full product lifecycle—from early innovation through post-market evidence generation and lifecycle management. In parallel, the CMO will contribute to advancing enterprise medical excellence priorities across Danaher Diagnostics, including evidence generation, in-field medical excellence, AI-enabled medical transformation, and the development of Danaher Diagnostics’ high-growth market medical and scientific affairs capabilities. This role is critical in ensuring clinical relevance, regulatory readiness, scientific credibility, and successful adoption of Radiometer’s solutions worldwide. The CMO will lead and scale a world-class medical organization that integrates evidence generation, clinical strategy, regulatory partnership, external scientific engagement, and patient-centered innovation to drive both clinical and business impact. The ideal leader brings deep diagnostics expertise, global medical leadership experience, strong commercial and operational acumen, and the ability to influence enterprise strategy in a highly matrixed environment. In this role, you will have the opportunity to: Enterprise Medical & Scientific Leadership Define and lead Radiometer’s global medical strategy across innovation, clinical development, product launch, and lifecycle management, ensuring alignment with enterprise growth priorities and patient care needs. Serve as the senior medical advisor to executive leadership, influencing portfolio strategy, innovation prioritization, and long-term scientific direction across acute care and future diagnostic platforms. Translate unmet clinical needs and healthcare trends into evidence-driven product strategies, Target Product Profiles (TPPs), and integrated evidence plans (IEPs). Evidence Strategy & Generation Lead global medical affairs and evidence generation strategies, serving as a key authority on clinical research practices and protocol design to support product development, clinical adoption, reimbursement readiness, and lifecycle value creation. Partner closely with Clinical Affairs leadership to support clinical validation strategies and oversee investigator-initiated studies (IIS), post-market evidence generation, real-world evidence initiatives, and publication strategies. Ensure clinical utility evidence effectively differentiates Radiometer solutions with clinicians, healthcare systems, regulators, and value-based care stakeholders. Cross-Functional Partnership & Governance Partner with Clinical Affairs, Regulatory Affairs, Quality, R&D, and platform leaders (e.g., Access, Government Affairs, Data, and emerging technologies) to ensure scientific rigor across product development, commercialization, and disease-focused initiatives at Radiometer.  Provide strategic leadership on medical risk management, patient safety, clinical claims, and regulatory interactions involving FDA, IVDR notified bodies, and other